These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8737130
21. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. Alvarez-Sala JL, Kardos P, Martínez-Beltrán J, Coronel P, Aguilar L. Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447 [Abstract] [Full Text] [Related]
22. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S. Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024 [Abstract] [Full Text] [Related]
23. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Holm S, Henning C, Grahn E, Lomberg H, Staley H. Scand J Infect Dis; 1995 Oct; 27(3):221-8. PubMed ID: 8539545 [Abstract] [Full Text] [Related]
24. [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. Otvagin IV, Kamanin EI, Strachunskiĭ LS, Kozlov SN. Vestn Otorinolaringol; 2001 Oct; (5):29-32. PubMed ID: 11699089 [Abstract] [Full Text] [Related]
25. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Upchurch J, Rosemore M, Tosiello R, Kowalsky S, Echols R. Otolaryngol Head Neck Surg; 2006 Oct; 135(4):511-7. PubMed ID: 17011409 [Abstract] [Full Text] [Related]
26. Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group. Weis M, Hendrick K, Tillotson G, Gravelle K. Clin Ther; 1998 Oct; 20(5):921-32. PubMed ID: 9829444 [Abstract] [Full Text] [Related]
27. Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia. Van den Brande P, Vondra V, Vogel F, Schlaeffer F, Staley H, Holmes C. Chest; 1997 Aug; 112(2):406-15. PubMed ID: 9266876 [Abstract] [Full Text] [Related]
28. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH. Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458 [Abstract] [Full Text] [Related]
29. Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice. Brodie DP, Griggs JV, Cunningham K. J Int Med Res; 1990 Jul; 18(3):235-9. PubMed ID: 2113874 [Abstract] [Full Text] [Related]
30. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Perry CM, Brogden RN. Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689 [Abstract] [Full Text] [Related]
31. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study. Donowitz GR, Brandon ML, Salisbury JP, Harman CP, Tipping DM, Urick AE, Talbot GH. Clin Ther; 1997 Jul; 19(5):936-53. PubMed ID: 9385482 [Abstract] [Full Text] [Related]
32. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy. Turik MA, Johns D. J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470 [Abstract] [Full Text] [Related]
33. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Califf RM, Simel DL, Ceftin and Flonase for Sinusitis (CAFFS) Investigators. JAMA; 2001 Dec 26; 286(24):3097-105. PubMed ID: 11754675 [Abstract] [Full Text] [Related]
34. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis. Buchanan PP, Stephens TA, Leroy B. Am J Rhinol; 2003 Dec 26; 17(6):369-77. PubMed ID: 14750614 [Abstract] [Full Text] [Related]
35. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Naber KG, Koch EM. Infection; 1993 Dec 26; 21(1):34-9. PubMed ID: 8449579 [Abstract] [Full Text] [Related]
36. Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis. Davies BI, Maesen FP, Teengs JP. Infection; 1987 Dec 26; 15(4):253-6. PubMed ID: 3312021 [Abstract] [Full Text] [Related]
37. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group. Aubier M, Verster R, Regamey C, Geslin P, Vercken JB. Clin Infect Dis; 1998 Jun 26; 26(6):1312-20. PubMed ID: 9636854 [Abstract] [Full Text] [Related]
38. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. Naber KG, di Silverio F, Geddes A, Guibert J. J Antimicrob Chemother; 1996 May 26; 37 Suppl A():135-44. PubMed ID: 8737133 [Abstract] [Full Text] [Related]
39. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil]. Dupuis G, Ebbo D, Evennou A, Pappo M. Rev Laryngol Otol Rhinol (Bord); 1989 May 26; 110(1):123-6. PubMed ID: 2491707 [Abstract] [Full Text] [Related]
40. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Kristo A, Uhari M, Luotonen J, Ilkko E, Koivunen P, Alho OP. Acta Paediatr; 2005 Sep 26; 94(9):1208-13. PubMed ID: 16278986 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]